Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Harvard Scientific (HVSF)Hot$$- male impotency medicine -- Ignore unavailable to you. Want to Upgrade?

To: Wally who wrote (2856)	1/22/1998 10:11:00 PM
From: Tomas	Respond to of 3906

Point taken. Believe me as the son of an ex Fed Gov't employee I know how those folks work, boy do I know how they work. Sorry Dad <g>. The point I was making is that I do not believe this to be the "typical" developing and bringing a new drug to approval. But hey, it only takes one person to hold up the process and send us all to the back of the line. My fear is that the (what appears to me anyway) mismanagement or at least constant changing of the guard will cause the FDA to require more than what would have been required. I mean each time they have to call the FDA there is a new guy running the show, at least on the management end. Funny there doesn't seem to be much hoopla and change in the Dr. end of things. At least that is a good sign (??). Tom